Ackman And Valeant Team Up To Pursue Takeover Of Allergan
Activist hedge fund manager Bill Ackman is bringing his sometimes bare-knuckle expertise at the takeover game to Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) as the highly efficient roll-up company targets Botox wrinkle treatment company Allergan, Inc. (NYSE:AGN) with a takeover offer.
SORRY! This content is exclusively for paying members. If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.
Activist hedge fund with successful track record at "encouraging" boards to make the "right" decisions teams with Valeant to acquire Allergan
The